# OnCo record paper-tailorx-nejm-2018 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-tailorx-nejm-2018/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-tailorx-nejm-2018" ;
  schema:name "TAILORx: adjuvant chemotherapy guided by the 21-gene recurrence score in hormone receptor-positive, node-negative breast cancer"@en ;
  schema:description "Women with hormone receptor-positive, HER2-negative, node-negative breast cancer and a mid-range 21-gene recurrence score did just as well with endocrine therapy alone as with chemotherapy added, sparing most of them chemotherapy."@en ;
  schema:url <https://onco.cc/key-papers/paper-tailorx-nejm-2018/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa1804710>, <https://pubmed.ncbi.nlm.nih.gov/29860917/> ;
  schema:sameAs <https://doi.org/10.1056/NEJMoa1804710> ;
  schema:datePublished "2018"^^xsd:gYear ;
  schema:author "Sparano JA, Gray RJ, Makower DF, et al." ;
  onco:cancers <https://onco.cc/cancers/hr-positive-early-high-risk/> ;
  onco:trials <https://onco.cc/trials/tailorx/> ;
  onco:journals <https://onco.cc/journals/nejm/> .